BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 20556670)

  • 1. Timing of subsequent fractures after an initial fracture.
    van Geel TA; Huntjens KM; van den Bergh JP; Dinant GJ; Geusens PP
    Curr Osteoporos Rep; 2010 Sep; 8(3):118-22. PubMed ID: 20556670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Odanacatib for the treatment of postmenopausal osteoporosis: results of the LOFT multicentre, randomised, double-blind, placebo-controlled trial and LOFT Extension study.
    McClung MR; O'Donoghue ML; Papapoulos SE; Bone H; Langdahl B; Saag KG; Reid IR; Kiel DP; Cavallari I; Bonaca MP; Wiviott SD; de Villiers T; Ling X; Lippuner K; Nakamura T; Reginster JY; Rodriguez-Portales JA; Roux C; Zanchetta J; Zerbini CAF; Park JG; Im K; Cange A; Grip LT; Heyden N; DaSilva C; Cohn D; Massaad R; Scott BB; Verbruggen N; Gurner D; Miller DL; Blair ML; Polis AB; Stoch SA; Santora A; Lombardi A; Leung AT; Kaufman KD; Sabatine MS;
    Lancet Diabetes Endocrinol; 2019 Dec; 7(12):899-911. PubMed ID: 31676222
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology and predictors of fractures associated with osteoporosis.
    Lips P
    Am J Med; 1997 Aug; 103(2A):3S-8S; discussion 8S-11S. PubMed ID: 9302892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of antiresorptive agents for preventing fractures in Japanese patients with an increased fracture risk: review of the literature.
    Iwamoto J; Sato Y; Takeda T; Matsumoto H
    Drugs Aging; 2012 Mar; 29(3):191-203. PubMed ID: 22372723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severity of prevalent vertebral fractures and the risk of subsequent vertebral and nonvertebral fractures: results from the MORE trial.
    Delmas PD; Genant HK; Crans GG; Stock JL; Wong M; Siris E; Adachi JD
    Bone; 2003 Oct; 33(4):522-32. PubMed ID: 14555255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of long-term strontium ranelate treatment on the risk of nonvertebral and vertebral fractures in postmenopausal osteoporosis: Results of a five-year, randomized, placebo-controlled trial.
    Reginster JY; Felsenberg D; Boonen S; Diez-Perez A; Rizzoli R; Brandi ML; Spector TD; Brixen K; Goemaere S; Cormier C; Balogh A; Delmas PD; Meunier PJ
    Arthritis Rheum; 2008 Jun; 58(6):1687-95. PubMed ID: 18512789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Denosumab for prevention of fractures in postmenopausal women with osteoporosis.
    Cummings SR; San Martin J; McClung MR; Siris ES; Eastell R; Reid IR; Delmas P; Zoog HB; Austin M; Wang A; Kutilek S; Adami S; Zanchetta J; Libanati C; Siddhanti S; Christiansen C;
    N Engl J Med; 2009 Aug; 361(8):756-65. PubMed ID: 19671655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Teriparatide and the risk of nonvertebral fractures in women with postmenopausal osteoporosis.
    Krege JH; Wan X
    Bone; 2012 Jan; 50(1):161-4. PubMed ID: 22036910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patients with prior vertebral or hip fractures treated with teriparatide in the Direct Assessment of Nonvertebral Fractures in Community Experience (DANCE) observational study.
    Beall DP; Feldman RG; Gordon ML; Gruber BL; Lane JM; Valenzuela G; Yim D; Alam J; Krege JH; Krohn K
    Osteoporos Int; 2016 Mar; 27(3):1191-1198. PubMed ID: 26556737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fracture prevention in postmenopausal osteoporosis: a review of treatment options.
    McCarus DC
    Obstet Gynecol Surv; 2006 Jan; 61(1):39-50. PubMed ID: 16359568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Osteoporosis Medication Use After Hip Fracture With Prevention of Subsequent Nonvertebral Fractures: An Instrumental Variable Analysis.
    Desai RJ; Mahesri M; Abdia Y; Barberio J; Tong A; Zhang D; Mavros P; Kim SC; Franklin JM
    JAMA Netw Open; 2018 Jul; 1(3):e180826. PubMed ID: 30646034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical fractures cluster in time after initial fracture.
    Laurs-van Geel TA; Center JR; Geusens PP; Dinant GJ; Eisman JA
    Maturitas; 2010 Dec; 67(4):339-42. PubMed ID: 20926211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Incidence of and prognosis for osteoporotic fracture].
    Muraki S; Yoshimura N
    Clin Calcium; 2006 Sep; 16(9):1431-37. PubMed ID: 16951464
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessment of the relationship between age and the effect of risedronate treatment in women with postmenopausal osteoporosis: a pooled analysis of four studies.
    Boonen S; Klemes AB; Zhou X; Lindsay R
    J Am Geriatr Soc; 2010 Apr; 58(4):658-63. PubMed ID: 20345865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between prior non-spine non-hip fractures or prevalent radiographic vertebral deformities known to be at least 10 years old and incident hip fracture.
    Schousboe JT; Fink HA; Lui LY; Taylor BC; Ensrud KE
    J Bone Miner Res; 2006 Oct; 21(10):1557-64. PubMed ID: 16995810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteoporosis and osteoporotic fracture occurrence and prevention in the elderly: a geriatric perspective.
    Boonen S; Dejaeger E; Vanderschueren D; Venken K; Bogaerts A; Verschueren S; Milisen K
    Best Pract Res Clin Endocrinol Metab; 2008 Oct; 22(5):765-85. PubMed ID: 19028356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of teriparatide adherence and persistence on fracture outcomes.
    Yu S; Burge RT; Foster SA; Gelwicks S; Meadows ES
    Osteoporos Int; 2012 Mar; 23(3):1103-13. PubMed ID: 22159748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of continuing or stopping alendronate after 5 years of treatment: the Fracture Intervention Trial Long-term Extension (FLEX): a randomized trial.
    Black DM; Schwartz AV; Ensrud KE; Cauley JA; Levis S; Quandt SA; Satterfield S; Wallace RB; Bauer DC; Palermo L; Wehren LE; Lombardi A; Santora AC; Cummings SR;
    JAMA; 2006 Dec; 296(24):2927-38. PubMed ID: 17190893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treating osteoporosis to prevent fractures: current concepts and future developments.
    Lorentzon M
    J Intern Med; 2019 Apr; 285(4):381-394. PubMed ID: 30657216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hip and other osteoporotic fractures increase the risk of subsequent fractures in nursing home residents.
    Lyles KW; Schenck AP; Colón-Emeric CS
    Osteoporos Int; 2008 Aug; 19(8):1225-33. PubMed ID: 18301857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.